Catalyst Wire Dossier Catalyst Wire Dossier

pemetrexed intrathecal injection

pemetrexed · Eli Lilly and Company
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for pemetrexed intrathecal injection, covering 2025-09-29 to 2025-09-29. Get the full timeline:

Most recent: Clinical Trial Update: Immune Checkpoint Inhibitor Combined With Pemetrexed Intrathecal Injection for Leptomeningeal Metastasis From Solid Tumors [Phase 1, Phase 2]

See pricing